Molecular engineering of HA-based lubricants for articular cartilage
用于关节软骨的 HA 基润滑剂的分子工程
基本信息
- 批准号:10712721
- 负责人:
- 金额:$ 61.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-21 至 2028-06-30
- 项目状态:未结题
- 来源:
- 关键词:AcuteAdhesionsAdhesivesAnimal ModelArchitectureAtomic Force MicroscopyBone TissueCartilageCartilage injuryChargeClinicClinicalDegenerative polyarthritisDeteriorationDevelopmentElectrostaticsEngineeringEnsureExhibitsExtracellular MatrixFamily suidaeFormulationFrictionGoalsHistologicHyaluronic AcidImageIndividualInjuryInterventionIntra-Articular InjectionsJointsLiquid substanceLubricantsLubricationLysineMeasurementMechanicsModelingMolecularMolecular WeightMonitorMovementOperative Surgical ProceduresOutcomePainPropertyPyrimidinonesResearchRoleSalineSlideSurfaceSynovial FluidSynovial MembraneTimeTissuesTraumaTraumatic ArthropathyUnited StatesWeight-Bearing stateanterior cruciate ligament injuryanterior cruciate ligament reconstructionarticular cartilagecartilage degradationchondroprotectiondesignhealingimprovedimproved outcomein vivoinflammatory markerjoint injurylubricinnovelnovel therapeutic interventionpreventrepairedsuccess
项目摘要
ABSTRACT
Altered lubrication of articular cartilage following joint injury increases friction between the sliding cartilage
surfaces, leads to deterioration of cartilage, and hastens the development of osteoarthritis (OA). OA due to joint
injury, termed as post-traumatic osteoarthritis (PTOA), is estimated to account for at least 12% of all OA cases
in the United States and approximately half of the individuals with an anterior cruciate ligament (ACL) injury
develop PTOA regardless of the ACL reconstruction. Replenishing the synovial fluid and thereby restoring the
articular cartilage lubrication has been demonstrated to benefit the joint. The overarching goal of the proposed
study is to investigate the potential of cartilage-adhering, self-healing hyaluronic acid molecules to prevent or
delay the degeneration of articular cartilage, and thereby osteoarthritis, following injury or trauma. The
molecularly engineered HA-based lubricants are designed to integrate the function of both hyaluronic acid and
lubricin, two key components of the synovial fluid, while exhibiting self-repairing ability. The self-healing
properties are incorporated to ensure both long-term retention and adaptability of the lubricant within the
mechanically active joint, while the cartilage adhering properties are expected to improve boundary lubrication.
We hypothesize that the dynamic cartilage-adhering molecules that integrate the molecular features of HA and
lubricin and simultaneously exhibit self-healing properties will protect the articular cartilage and prevent or slow
down the progression of PTOA. Towards this, we will: (i) develop cartilage-adhering, self-healing HA molecules
and determine the effect of molecular architecture-lubrication function relationship, (ii) determine the effect of the
molecular architecture of the proposed novel HA-based lubricants on chondroprotection by using a joint-on-chip
platform, and (iii) determine the effect of these lubricants on mitigating the development of post-traumatic
osteoarthrits. The proposed studies will enable a new paradigm in which intra-articular injection of self-healing
HA-bottle brush molecules could be an important treatment following acute injury to ameliorate or delay PTOA,
or they could be used as an adjunct after surgical repair to improve the outcome.
摘要
关节损伤后关节软骨的润滑改变增加了滑动软骨之间的摩擦
表面,导致软骨退化,加速骨性关节炎(OA)的发展。由关节引起的骨性关节炎
损伤,被称为创伤后骨关节炎(PTOA),估计至少占所有OA病例的12%
在美国,前交叉韧带(ACL)损伤的个人中约有一半
无论前交叉韧带重建如何,都要发展PTOA。补充滑液,从而恢复
关节软骨润滑已被证明有益于关节。建议的总体目标是
这项研究是为了研究软骨黏附、自我修复的透明质酸分子预防或
延缓损伤或创伤后关节软骨的退化,从而延缓骨关节炎。这个
分子工程HA润滑剂旨在整合透明质酸和透明质酸的功能
润滑剂,滑液的两个关键成分,同时显示出自我修复能力。自我疗愈
将各种性能结合在一起,以确保润滑油在
关节具有机械活性,而软骨的粘附性有望改善边界润滑。
我们假设,整合了HA和HA的分子特征的动态软骨黏附分子
润滑剂同时表现出自我修复性能,将保护关节软骨,防止或减缓
延缓了PTOA的进展。为此,我们将:(I)开发软骨粘连、自我修复的HA分子
确定了分子构型-润滑功能关系的影响,(Ii)确定了分子构型-润滑功能关系的影响
基于片上关节的新型HA基软骨保护润滑剂的分子结构
平台,以及(3)确定这些润滑剂在减轻创伤后发展方面的作用
骨关节。拟议的研究将使一种新的范式成为可能,在这种范式中,关节内注射自我修复
HA-瓶刷分子可能是急性损伤后改善或延迟PTOA的重要治疗方法,
或者,它们可以作为手术修复后的辅助工具,以改善结果。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Shyni Varghese其他文献
Shyni Varghese的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Shyni Varghese', 18)}}的其他基金
Localization of adenosine to promote fracture healing
腺苷定位促进骨折愈合
- 批准号:
10461465 - 财政年份:2022
- 资助金额:
$ 61.19万 - 项目类别:
Localization of adenosine to promote fracture healing
腺苷定位促进骨折愈合
- 批准号:
10700832 - 财政年份:2022
- 资助金额:
$ 61.19万 - 项目类别:
Modulation of local adenosine signaling to attenuate fracture pain
调节局部腺苷信号传导以减轻骨折疼痛
- 批准号:
10543700 - 财政年份:2021
- 资助金额:
$ 61.19万 - 项目类别:
Modulation of local adenosine signaling to attenuate fracture pain
调节局部腺苷信号传导以减轻骨折疼痛
- 批准号:
10390489 - 财政年份:2021
- 资助金额:
$ 61.19万 - 项目类别:
Modulation of local adenosine signaling to attenuate fracture pain
调节局部腺苷信号传导以减轻骨折疼痛
- 批准号:
10614931 - 财政年份:2021
- 资助金额:
$ 61.19万 - 项目类别:
Modulation of local adenosine signaling to attenuate fracture pain
调节局部腺苷信号传导以减轻骨折疼痛
- 批准号:
10227375 - 财政年份:2021
- 资助金额:
$ 61.19万 - 项目类别:
Modulation of local adenosine signaling to attenuate fracture pain
调节局部腺苷信号传导以减轻骨折疼痛
- 批准号:
10812649 - 财政年份:2021
- 资助金额:
$ 61.19万 - 项目类别:
Bioinspired Synthetic Grafts for Bone Regeneration
用于骨再生的仿生合成移植物
- 批准号:
9551215 - 财政年份:2017
- 资助金额:
$ 61.19万 - 项目类别:
Adenosine A2B Receptor in Bone Health and Osteoporosis
腺苷 A2B 受体在骨骼健康和骨质疏松症中的作用
- 批准号:
9551206 - 财政年份:2017
- 资助金额:
$ 61.19万 - 项目类别:
相似海外基金
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y004841/1 - 财政年份:2024
- 资助金额:
$ 61.19万 - 项目类别:
Research Grant
Defining a role for non-canonical mTORC1 activity at focal adhesions
定义非典型 mTORC1 活性在粘着斑中的作用
- 批准号:
BB/Y001427/1 - 财政年份:2024
- 资助金额:
$ 61.19万 - 项目类别:
Research Grant
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y005414/1 - 财政年份:2024
- 资助金额:
$ 61.19万 - 项目类别:
Research Grant
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
- 批准号:
10669829 - 财政年份:2023
- 资助金额:
$ 61.19万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10587090 - 财政年份:2023
- 资助金额:
$ 61.19万 - 项目类别:
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
通过预防术后粘连改善剖宫产的产妇结局
- 批准号:
10821599 - 财政年份:2023
- 资助金额:
$ 61.19万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10841832 - 财政年份:2023
- 资助金额:
$ 61.19万 - 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
- 批准号:
10532480 - 财政年份:2022
- 资助金额:
$ 61.19万 - 项目类别:
I-Corps: A Sprayable Tissue-Binding Hydrogel to Prevent Postsurgical Cardiac Adhesions
I-Corps:一种可喷雾的组织结合水凝胶,可防止术后心脏粘连
- 批准号:
10741261 - 财政年份:2022
- 资助金额:
$ 61.19万 - 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
- 批准号:
10674894 - 财政年份:2022
- 资助金额:
$ 61.19万 - 项目类别: